| Nov 22 2024 |
Massachusetts Supreme Court Rules Online Tracking Technologies Do Not Violate State Wiretap Law |
Robinson & Cole LLP |
| Nov 21 2024 |
DOL’s Wage and Hour Division Weighs in on FMLA Use for Clinical Trials |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Nov 21 2024 |
Santa is Bringing Long-Awaited Regulatory Changes to Massachusetts Pharmacy Licensure |
Polsinelli PC |
| Nov 21 2024 |
Alabama CON Report - November 2024 |
Bradley Arant Boult Cummings LLP |
| Nov 21 2024 |
You See Health, Whistleblower Saw Fraud: Uncovering a $23 Million Healthcare Fraud Scheme |
Tycko & Zavareei LLP |
| Nov 21 2024 |
Let’s Talk Compliance Episode 35: Let’s Talk Compliance: Physician Compensation Plans and Trends of 2024 [Podcast] |
Foley & Lardner LLP |
| Nov 21 2024 |
The 2025 Final Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know |
ArentFox Schiff LLP |
| Nov 21 2024 |
Website Use of Third-Party Tracking Software Not Prohibited Under Massachusetts Wiretap Act |
Hunton Andrews Kurth |
| Nov 20 2024 |
Biomanufacturing Interagency Working Group Identifies Actions to Increase U.S. Biomanufacturing Capacity |
Bergeson & Campbell, P.C. |
| Nov 20 2024 |
New York Paid Family Leave Law: Are You Ready for 2025? |
Proskauer Rose LLP |
| Nov 20 2024 |
More Ontario Employment Changes: What Employers Need to Know |
Mintz |
| Nov 20 2024 |
California Department of Public Health Rejects Petition Requesting Synthetic Dye Warnings |
Keller and Heckman LLP |
| Nov 20 2024 |
Third Circuit Refuses to Enforce Preliminary Reinstatement Order Issued By OSHA |
Proskauer Rose LLP |
| Nov 20 2024 |
FDA Clinical Investigations: New Guidance on Electronic Systems |
Foley & Lardner LLP |
| Nov 20 2024 |
Maryland’s Impending FAMLI Program: What Employers Need to Know Now |
Jackson Lewis P.C. |
| Nov 20 2024 |
Newly Enacted Law Expands Earned Sick Time in Massachusetts |
CMBG3 Law |
| Nov 20 2024 |
California Ballot Proposition 34 Targets Spending by Certain 340B Covered Entities |
McDermott Will & Emery |
| Nov 19 2024 |
Protecting Workers From Valley Fever: Best Practices and Cal/OSHA Guidelines for High-Risk Jobs [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Nov 19 2024 |
Unpacking Johnson & Johnson’s Lawsuit Over 340B Rebate Model |
Mintz |
| Nov 19 2024 |
Alaska Paid Sick Leave Law: Requirements Employers Need to Know |
Jackson Lewis P.C. |
| Nov 19 2024 |
Contractor Successfully Recovers Costs Associated with Government-Mandated COVID-19-Related Quarantine |
Bradley Arant Boult Cummings LLP |
| Nov 19 2024 |
Sweet Reward: Whistleblower Team Receives Over $8 Million for Reporting Alleged CSID Testing Kickback Scheme |
Tycko & Zavareei LLP |
| Nov 19 2024 |
How to Effectively Utilize the MSHA Closeout Conference |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Nov 19 2024 |
Massachusetts Paid Family and Medical Leave Program: November 2024 End-of-Year Update |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Nov 19 2024 |
FDA Requests Information on PFAS in Seafood |
Keller and Heckman LLP |
| Nov 19 2024 |
Trending in Telehealth: October 29 – November 11, 2024 |
McDermott Will & Emery |
| Nov 19 2024 |
This Week in 340B: November 12 – 18, 2024 |
McDermott Will & Emery |
| Nov 18 2024 |
Still in Telemedicine Limbo: DEA Issues Third Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2025 |
Polsinelli PC |
| Nov 18 2024 |
California Passes Law Regulating Generative AI Use in Healthcare |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 18 2024 |
DEA Extends Telehealth Lifeline for Patients |
Robinson & Cole LLP |
| Nov 18 2024 |
DEA Issues Third Extension to Public Health Emergency Telemedicine Prescribing Flexibilities, Through 2025 |
Epstein Becker & Green, P.C. |
| Nov 18 2024 |
Calling All SNFs… and All of Your Operational Associates – Get Ready Now: Sweeping New Disclosure Requirements Under The Updated 855A |
Polsinelli PC |
| Nov 18 2024 |
Healthcare Preview for the Week of: November 18, 2024 [Podcast] |
McDermott Will & Emery |
| Nov 18 2024 |
Granting FMLA Leave for Clinical Trials: Five Key Points from the DOL’s New Guidance for Employers |
Jackson Lewis P.C. |
| Nov 18 2024 |
Multistate Monday, Election Edition: Legislative Action in the Works as the Ballot Boxes Open [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
